Literature DB >> 24219067

Origin of Swedish hemophilia B mutations.

C Halldén1, A Mårtensson, D Nilsson, T Säll, C Lind-Halldén, A C Lidén, R Ljung.   

Abstract

BACKGROUND: More than 1100 mutations that cause hemophilia B (HB) have been identified. At the same time, specific F9 mutations are present at high frequencies in certain populations, which raise questions about the origin of HB mutations.
OBJECTIVES: To describe the mutation spectrum of all HB families in Sweden and investigate if mutations appearing in several families are due to independent recurrent mutations (RMs) or to a common mutation event (i.e. are identical by descent (IBD)). PATIENTS/
METHODS: The registered Swedish HB population consists of patients from 86 families. Mutations were identified by resequencing and identical haplotypes were defined using 74 markers and a control population of 285 individuals. The ages of IBD mutations were estimated using ESTIAGE.
RESULTS: Out of 77 presumably unrelated patients with substitution mutations, 47 patients (61%) had mutations in common with other patients. Haplotyping of the 47 patients showed that 24 patients had IBD mutations (51%) with estimated ages of between two and 23 generations. A majority of these patients had mild disease. Eight of the 15 mutations observed in more than one family were C>T transitions in CpG sites and all eight were RMs.
CONCLUSIONS: The association of IBD mutations with a mild phenotype is similar to what has been previously observed in hemophilia A. Noteworthy features of the mutations that are common to more than one family are the equal proportions of patients with RM and IBD mutations and the correlation between the occurrence of RMs and C>T transitions at CpG sites.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  factor IX; founder effect; haplotypes; hemophilia B; mutation

Mesh:

Substances:

Year:  2013        PMID: 24219067     DOI: 10.1111/jth.12410

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  4 in total

1.  F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.

Authors:  Alessio Branchini; Massimo Morfini; Barbara Lunghi; Donata Belvini; Paolo Radossi; Loredana Bury; Maria Luisa Serino; Paola Giordano; Dorina Cultrera; Angelo Claudio Molinari; Mariasanta Napolitano; Elisabetta Bigagli; Giancarlo Castaman; Mirko Pinotti; Francesco Bernardi
Journal:  J Thromb Haemost       Date:  2021-10-24       Impact factor: 16.036

Review 2.  Hemophilia B: molecular pathogenesis and mutation analysis.

Authors:  A C Goodeve
Journal:  J Thromb Haemost       Date:  2015-05-18       Impact factor: 5.824

3.  Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening.

Authors:  Eric Manderstedt; Rosanna Nilsson; Christina Lind-Halldén; Rolf Ljung; Jan Astermark; Christer Halldén
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

4.  Hemophilia management: Huge impact of a tiny difference.

Authors:  Fabienne Kloosterman; Anne-Fleur Zwagemaker; Amal Abdi; Samantha Gouw; Giancarlo Castaman; Karin Fijnvandraat
Journal:  Res Pract Thromb Haemost       Date:  2020-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.